These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9610462)

  • 21. [Medical indications of labor induction: a comparison between intravaginal misoprostol and intravenous prostaglandin E2].
    Jouatte F; Subtil D; Marquis P; Plennevaux JL; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Dec; 29(8):763-771. PubMed ID: 11139713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elective cervical ripening in women beyond the 290th day of pregnancy: a randomized trial comparing 2 dinoprostone preparations.
    Facchinetti F; Venturini P; Fazzio M; Volpe A
    J Reprod Med; 2007 Oct; 52(10):945-9. PubMed ID: 17977171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abruptio placentae associated with misoprostol use in women with preeclampsia.
    Fontenot MT; Lewis DF; Barton CB; Jones EM; Moore JA; Evans AT
    J Reprod Med; 2005 Sep; 50(9):653-8. PubMed ID: 16363752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of concurrent oxytocin with a sustained-release dinoprostone vaginal insert for labor induction at term.
    Christensen FC; Tehranifar M; Gonzalez JL; Qualls CR; Rappaport VJ; Rayburn WF
    Am J Obstet Gynecol; 2002 Jan; 186(1):61-5. PubMed ID: 11810086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized comparison between intravaginal misoprostol and prostaglandin E2 for labor induction.
    Sifakis S; Angelakis E; Avgoustinakis E; Fragouli Y; Mantas N; Koukoura O; Vardaki E; Koumantakis E
    Arch Gynecol Obstet; 2007 Apr; 275(4):263-7. PubMed ID: 17028904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dinoprostone: slow release vaginal insert (Propess) and intracervical gel (Prepidil) for the induction of labour with unriped cervix].
    Grignaffini A; Soncini E; Anfuso S; Ronzoni E
    Minerva Ginecol; 2004 Oct; 56(5):413-8. PubMed ID: 15531859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized trial that compared intravaginal misoprostol and dinoprostone vaginal insert in pregnancies at high risk of fetal distress.
    Rozenberg P; Chevret S; Sénat MV; Bretelle F; Paule Bonnal A; Ville Y
    Am J Obstet Gynecol; 2004 Jul; 191(1):247-53. PubMed ID: 15295374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two preparations of dinoprostone for pre-induction of labour in nulliparous women with very unfavourable cervical condition: a randomised clinical trial.
    Facchinetti F; Venturini P; Verocchi G; Volpe A
    Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):189-93. PubMed ID: 15808378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Misoprostol dose selection in a controlled-release vaginal insert for induction of labor in nulliparous women.
    Castañeda CS; Izquierdo Puente JC; Leon Ochoa RA; Plasse TF; Powers BL; Rayburn WF
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1071-5. PubMed ID: 16157114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outpatient cervical ripening using a sustained-release prostaglandin E2 vaginal insert.
    Tassone SA; Pearman CR; Rayburn WF
    J Reprod Med; 2001 Jun; 46(6):599-600. PubMed ID: 11441687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial of intracervical versus posterior fornix dinoprostone for induction of labor.
    Perry MY; Leaphart WL
    Obstet Gynecol; 2004 Jan; 103(1):13-7. PubMed ID: 14704238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of induction with vaginal prostaglandin E2 versus spontaneous of labor in grand multiparous women.
    Zamzami TY
    Arch Gynecol Obstet; 2005 Dec; 273(3):176-9. PubMed ID: 16160873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacological induction of labour: benefits and risks].
    Romanelli M; Ribiani E; Burnelli L; Luzi G; Affronti G; Di Renzo GC
    Minerva Ginecol; 2007 Aug; 59(4):347-55. PubMed ID: 17923826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine rupture during induced trial of labor among women with previous cesarean delivery.
    Ravasia DJ; Wood SL; Pollard JK
    Am J Obstet Gynecol; 2000 Nov; 183(5):1176-9. PubMed ID: 11084562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Uterine rupture without predisposing factors after a single vaginal PgE2 administration in prolonged pregnancy].
    Zieger W; Leveringhaus A; Wischnik A; Melchert F
    Zentralbl Gynakol; 1995; 117(1):51-3. PubMed ID: 7879464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dinoprostone vaginal slow-release system (Propess) compared to expectant management in the active treatment of premature rupture of the membranes at term: impact on maternal and fetal outcomes.
    Larrañaga-Azcárate C; Campo-Molina G; Pérez-Rodríguez AF; Ezcurdia-Gurpegui M
    Acta Obstet Gynecol Scand; 2008; 87(2):195-200. PubMed ID: 18231888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaginal misoprostol in managing premature rupture of membranes.
    Ayad IA
    East Mediterr Health J; 2002; 8(4-5):515-20. PubMed ID: 15603033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial.
    Meyer M; Pflum J; Howard D
    Obstet Gynecol; 2005 Mar; 105(3):466-72. PubMed ID: 15738009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Administration of prostaglandin E2 in premature rupture of the membranes].
    Rübig A; Broer KH
    Z Geburtshilfe Perinatol; 1991; 195(4):159-62. PubMed ID: 1950059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dinoprostone vaginal pessary for induction of labour: safety of use for up to 24 h.
    Tathem K; Harris LJ; O'Rourke P; Kimble RM
    Aust N Z J Obstet Gynaecol; 2012 Dec; 52(6):582-7. PubMed ID: 23004009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.